Skip to main content
. Author manuscript; available in PMC: 2014 Jun 6.
Published in final edited form as: J Allergy Clin Immunol. 2014 May;133(5):1289–130112. doi: 10.1016/j.jaci.2014.02.006

FIG 1.

FIG 1

Kaplan-Meier plots by cluster of the cumulative probability of a first course of prednisone (A) or initiation of additional asthma controller therapies (beclomethasone or other; B) during the 4-year follow-up period of the CAMP trial.